Why AmSpa, the AMA, and the FDA Are All Pushing Med Spa Compliance — And What It Means for Your Clinic

Something significant has shifted in the medical aesthetics industry over the past 18 months. The organizations and regulatory bodies that shape how med spas and wellness clinics operate — the American Med Spa Association, the American Medical Association, the FDA, state medical boards from New York to Georgia to California — are all saying the same thing, from different directions, in increasingly forceful terms.

The era of loosely supervised aesthetic businesses operating in regulatory gray zones is ending. And the clinics that built their operations around real physician oversight, documented compliance infrastructure, and genuine clinical accountability are not just surviving this shift — they are positioned to dominate what comes next.

This post breaks down exactly what the industry's most important voices have been saying, why it matters right now, and why Wellness MD Group was built for precisely this regulatory moment.

The Industry's Wake-Up Call: What the Data Actually Shows

To understand why the compliance conversation has reached a fever pitch in 2026, you have to look at where the industry came from. The med spa market grew from approximately 1,600 locations in 2010 to an estimated 9,500 to 12,000 locations today. That is a six-fold increase in roughly 15 years — growth that outpaced the regulatory infrastructure designed to govern it in most states.

A study published in the journal Dermatologic Surgery and highlighted by the American Medical Association found that 36 states have virtually no specific regulatory oversight framework for medical spas. In many of those states, clinics offering Botox, IV therapy, GLP-1 weight loss programs, and hormone therapies were operating with little formal accountability to any licensing body beyond the individual licenses of the staff they employed.

That gap between rapid industry growth and regulatory oversight created the conditions for widespread non-compliance — not always intentional, but pervasive. And now the regulatory environment is catching up.

AmSpa's Position: Med Spas Are Medical Practices, Full Stop

The American Med Spa Association has been the industry's most consistent and credible voice on compliance for years. AmSpa's core position — that med spas are medical practices first, aesthetic businesses second — has informed its educational programs, its annual Medical Spa Show, its state-by-state legal guidance, and its ongoing advocacy with state legislatures and medical boards.

When the FDA issued a landmark warning letter in April 2026 to a Texas medical spa, Pure Indulgence Aesthetics in Southlake, following a December 2025 inspection, AmSpa's response was direct. The letter — reportedly the first-ever Drug Supply Chain Security Act (DSCSA) warning letter targeting a medical spa dispenser — cited failures in the clinic's documentation, supplier verification, and oversight of prescription injectable products including Botox. AmSpa stated plainly that the action "does not introduce new rules" but rather enforces "longstanding federal requirements that apply whenever prescription drugs are dispensed or administered," and called on clinics to ensure that physician oversight is "clearly defined, actively exercised, and documented."

That language — clearly defined, actively exercised, documented — is the standard AmSpa has been building toward for years. It is also a direct rebuke of the ghost directing model that has characterized too many physician oversight arrangements in the industry: a physician's name on an agreement, a monthly fee, and no meaningful engagement with the clinic's actual operations.

AmSpa has consistently invested in education, certification programs, and legal resources to help clinic owners understand what real compliance looks like. The Medical Spa Show annually convenes thousands of clinic owners, operators, and medical directors around exactly these topics. The association's investment in this space reflects a clear organizational belief: the clinics that survive long-term regulatory scrutiny are the ones that treated compliance as a foundation, not an afterthought.

The AMA: Sounding the Alarm on a National Scale

The American Medical Association's 2026 spotlight on med spa regulation marked an escalation in the professional medical community's engagement with the aesthetics industry. The AMA's coverage of the Dermatologic Surgery study — which documented the absence of meaningful regulatory oversight in 36 states — framed the issue as a patient safety crisis as much as a regulatory one.

The AMA's position aligns with a broader push from physician organizations to ensure that procedures performed on patients are performed by appropriately licensed professionals, under genuine physician oversight, in settings that meet clinical standards. When a patient receives an injectable treatment, an IV infusion, or a GLP-1 prescription at a wellness clinic, they are receiving a medical service — and they deserve the same protections that come with any other medical service.

The AMA's engagement with this issue signals that it is no longer being treated as a niche regulatory matter for aesthetics insiders. It is a mainstream patient safety question, and the organizations that shape national healthcare policy are paying attention.

The FDA: Enforcement Has Arrived

The April 2026 FDA warning letter to Pure Indulgence Aesthetics was described by industry observers as a milestone. Federal enforcement actions against medical spas have been rare — but that era appears to be ending. The FDA's application of the Drug Supply Chain Security Act to a medical spa dispenser sends a clear message: the federal government considers aesthetic clinics handling prescription injectables to be part of the regulated prescription drug supply chain, regardless of their size or the cosmetic framing of their services.

The DSCSA requires that dispensers — entities that receive and administer prescription drugs — verify that their suppliers are authorized, maintain transaction records, and respond appropriately to suspected illegitimate products. For a med spa receiving Botox, fillers, or any other prescription injectable, these are not optional administrative tasks. They are federal compliance requirements. The FDA's decision to issue a formal warning letter — rather than simply a 483 observation form — after determining that the clinic's corrective action response was insufficient signals that the agency is prepared to escalate when clinics fail to take these obligations seriously.

The implication for every med spa and wellness clinic in the country is the same: sourcing, documentation, and physician oversight of drug handling are not the exclusive concern of your state medical board. They are federal matters too.

State Medical Boards: The Enforcement Wave Is Already Here

While federal enforcement makes headlines, the most immediate regulatory risk for most med spas comes from state-level action — and that action has accelerated significantly across multiple major markets.

New York: 100% Violation Rate

In December 2025, the New York City Council's Oversight and Investigations Division released a report on medical spa compliance following coordinated inspections of 15 clinics across New York City. Every single inspected location was found to be offering medical procedures without required licensure and oversight — a 100 percent violation rate. Of the four cases that had been adjudicated at the time of publication, all four resulted in license revocation.

The report explicitly identified "paper medical directors and loose supervision models" as a primary enforcement focus, and called for state legislation requiring clearer disclosure to consumers about the scope of services a given clinic is licensed to provide. The New York Office, Program, and Management Committee (OPMC) and other state bodies have measurably increased disciplinary actions against med spa medical directors and owners through 2024 and 2026.

California: New Laws with Real Teeth

California's 2026 legislative updates significantly expanded the enforcement framework for med spa and wellness clinic compliance. The new laws added penalties and monitoring requirements to longstanding CPOM restrictions, tightened the rules around what MSOs can and cannot control in clinical decision-making, and introduced requirements for patient-specific orders that go beyond what a standard good faith exam alone provides. California's Medical Board has increased disciplinary actions against medical directors and clinic operators, and the state's new MSO enforcement posture — which was shaped in part by SB 351 — creates meaningful consequences for the corporate structures that many non-physician-owned clinics have used to operate in gray zones.

Georgia: Banning the Matchmaker Model

In May 2026, the Georgia Composite Medical Board issued a position statement that directly targeted physician matchmaker platforms — services that connect physicians with med spas for nominal supervision arrangements without genuine oversight. The GCMB's position makes it explicit that arrangements where a physician's connection to a practice is mediated by a third-party matching service, without substantive engagement in clinical oversight, do not meet Georgia's standards for physician supervision. This is a direct attack on the ghost directing model at the structural level.

Indiana, Florida, and the National Trend

Indiana, Florida, Arizona, and Iowa all introduced new legislation in early 2026 addressing med spa licensing, supervision requirements, and scope-of-practice rules. Florida's SB 1728, if enacted, would require separate pharmacy licensing for clinics that handle prescriptions in-house — an additional compliance layer that many clinics are not currently prepared for. Across virtually every major market, the legislative and regulatory trend is moving in one direction: more scrutiny, more documentation requirements, and clearer enforcement of oversight standards that have existed on paper but gone unenforced for years.

The Collapse of the Ghost Director Model

Across all of these enforcement actions and regulatory developments, a single theme emerges with striking consistency: the ghost director model is collapsing. The arrangement — a physician whose name appears on an agreement, who collects a monthly fee, and who has no meaningful engagement with the clinic's protocols, patient care, or compliance obligations — is being targeted simultaneously by the FDA, state medical boards, physician associations, and industry organizations.

The standard regulators are now applying is not whether a clinic has a medical director. It is whether that medical director is "clearly defined, actively exercised, and documented." It is whether chart reviews happen. Whether standing orders are current and physician-signed. Whether the physician can be reached for clinical questions. Whether the clinic's drug sourcing, documentation, and patient evaluation protocols meet the standards the physician is ostensibly supervising.

Clinics that cannot demonstrate genuine physician oversight when an inspector arrives — or when an adverse event triggers a board investigation — are learning that a signed agreement is not protection. It is evidence of an arrangement that does not meet the required standard.

Why Wellness MD Group Was Built for This Moment

Wellness MD Group is a physician-led MSO. That is not a marketing phrase — it is the structural reality of how we operate. Every medical director placement we make is a licensed physician who provides genuine oversight: signed standing orders specific to your service menu, telehealth good faith exam infrastructure, protocol review, clinical consultation availability, and documented engagement with your practice's operations.

We do not run a matchmaker platform. We do not place physicians who sign agreements and disappear. The enforcement environment that AmSpa, the AMA, the FDA, and state medical boards have been building toward for the past several years is one that our model was designed to withstand — because real oversight was always the standard we held ourselves to, not one we are scrambling to meet now that regulators are enforcing it.

Here is what that looks like in practice for Wellness MD Group partner clinics:

Physician Oversight That Meets the 2026 Standard

Every Wellness MD Group medical director provides the documented, active oversight that regulators are now specifically looking for. Standing orders are physician-signed and service-specific. Good faith exams are conducted by licensed prescribers through our telehealth infrastructure, documented in a compliant EHR, and tied to the treatment being authorized. The physician is reachable. Chart reviews happen. Protocols are updated when your service menu changes. This is what genuine oversight looks like — and it is what the current enforcement environment is measuring.

CPOM and MSO Structure Done Right

For non-physician owned clinics in CPOM states, Wellness MD Group manages the MSO and Professional Corporation structure that keeps your business on the right side of California's CPOM enforcement, Georgia's GCMB position statement, and the broader national movement toward stricter corporate practice of medicine compliance. We understand how the line between business operations and clinical decision-making is drawn, and we structure our engagements to respect it — which is exactly what the 2026 California laws, and their equivalents in other states, require.

Drug Supply Chain Compliance

The FDA's April 2026 warning letter to the Texas med spa was not just about physician oversight — it was about drug sourcing, documentation, and supply chain accountability. Wellness MD Group connects partner clinics to pharmacy and supplier relationships that meet federal DSCSA requirements and state board credential standards. We do not work with vendors whose compliance credentials are in question, and we help Ohio partner clinics satisfy the TDDD license requirements that govern how prescription drugs are stored and administered in that state.

Healthcare Compliance Pros: The Full Stack

Our partnership with Healthcare Compliance Pros (HCP) gives Wellness MD Group partner clinics access to the full compliance infrastructure — HIPAA, OSHA, CMS/OIG exclusion monitoring, billing integrity through SENTRY Coding Intelligence, background checks and credentialing, and a 130+ course LMS that trains your staff on the P&Ps and SOPs that a Board of Pharmacy inspector, a state medical board investigator, or an FDA auditor will look for. This is not a compliance add-on. It is the operational foundation that makes everything else defensible.

LegitScript Certification

Compliant marketing is part of the compliance picture too. Wellness MD Group is an enterprise LegitScript partner with a documented track record of first-round approvals for clinic applications. In a regulatory environment where Google, Meta, and every major digital advertising platform requires LegitScript certification for healthcare and wellness advertising, clinics that are not certified are both legally exposed and competitively disadvantaged. We help clinics get certified and stay certified — including navigating the increasingly complex rules around GLP-1 advertising, peptide content, and telehealth services.

The Opportunity in the Compliance Era

Everything described in this post — the FDA warning letters, the state enforcement actions, the ghost director crackdowns, the new legislation — sounds like a threat to the med spa industry. And it is, for clinics that built their operations on shortcuts.

For clinics that built their operations correctly, it is an opportunity. Every non-compliant competitor that faces an enforcement action, loses a pharmacy relationship, or shuts down under regulatory pressure is a clinic whose clients need somewhere to go. Every client who learns to ask about physician oversight, medical director qualifications, and compliance credentials is a client who will choose the clinic that can answer those questions confidently.

AmSpa, the AMA, the FDA, and state medical boards are not destroying the med spa industry. They are separating the clinics that were built to last from the ones that were not. Wellness MD Group exists to make sure our partner clinics are in the first category.

If you are ready to build the compliance infrastructure that the 2026 regulatory environment demands — and that your clients increasingly expect — contact Wellness MD Group to learn what a partnership with us looks like for your practice.